Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
乐伐替尼联合程序性死亡受体-1抑制剂(伴或不伴经动脉化疗栓塞术)治疗不可切除肝细胞癌的疗效和安全性
期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S485047
Jin, Ming; Jiang, Zhi-Qing; Qin, Jia-Hui; Qin, Hui-Xia; Jiang, Kai-Wen; Ya, Hou-Xiang; Gu, Jing; Gui, Mo-Rui; Li, Yao-Hua; Xu, Long-Kuan; Fu, Hai-Xiao; Xiao, Xu-Hua; Li, Shu-Qun